Balancing Current and Future Patients
Steve Issenman | May 29, 2024 America’s elected officials – Republicans and Democrats, from the Northeast and Southwest, representing big states and small – all care deeply about making the world a better place. But while their perspectives may sharply differ on many issues, they or a loved one – a parent, a child, a […]
OPINION: Beware of New Regs
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. May 20, 2024 – New Jersey has long been home to some of the world’s leading research-based biopharmaceutical companies. Many have made New Jersey a base for their global, North American, or U.S. operations. Aside from their contributions to human health and patients worldwide, our […]
Chrissy Buteas: Saving lives around the world by finding cures in New Jersey
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. Trenton, April 29, 2024 – New Jersey – home to the Sopranos, the Jersey Shore, full-service gas stations and the long-running debate over pork roll versus Taylor ham. Gritty, smart as hell, and loyal to our Jets . . . or Giants . . . […]
HealthCare Institute of New Jersey Announces the Appointment of Chrissy Buteas as President and Chief Executive Officer
Trenton, NJ – March 26, 2024 – Chris Lepore, Chair of the Board of Trustees of the HealthCare Institute of New Jersey (HINJ) (www.hinj.org) and Vice President, U.S. State Affairs, Johnson & Johnson, today announced the appointment of Christine “Chrissy” Buteas as HINJ’s next President and Chief Executive Officer following the retirement of long-time President […]
Op-Ed: Allowing ‘March-In’ Rights Would Threaten Medical Innovation and NJ Economy
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer. Move by Biden administration could devastate intellectual property rights and life sciences research New Jersey has long been a cradle of American innovation. Known globally as the “medicine chest of the world,” it is home to more biotechnology, medical device, biopharmaceutical and diagnostics […]
HealthCare Institute of New Jersey Statement on WTO TRIPS Waiver Decision
Trenton, March 2, 2024 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the World Trade Organization’s decision on expansion of the TRIPS waiver: “The HealthCare Institute of New Jersey (HINJ) applauds the World Trade Organization’s decision not to expand the Trade-Related Aspects […]
HealthCare Institute of New Jersey Statement on Senate HELP Hearing on Lowering Health Care Costs
Trenton, February 8, 2024 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the Senate HELP Committee’s hearing on lowering health care costs: “As the ‘medicine chest of the world,’ we are enormously proud that New Jersey is home to so many of […]
HealthCare Institute of New Jersey statement on the retirement of President and Chief Executive Officer Dean J. Paranicas
Trenton, December 11, 2023 ― Chris Lepore, Chair of the Board of Trustees of the HealthCare Institute of New Jersey (HINJ) and Vice President, U.S. State Affairs, Johnson & Johnson, released the following statement announcing the retirement of HINJ President and Chief Executive Officer Dean J. Paranicas: “After nearly 13 impactful years as President and […]
Healthcare Institute of New Jersey Statement on First List of Medicines Subject to Government Price Setting
Trenton, August 29, 2023 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the Administration’s announcement of the first ten prescription medicines subject to government price setting: (Read full statement here)
Opinion: Life Sciences Save More Than Lives
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer. The storied achievements of our life sciences sector – our biopharmaceutical, biotech, diagnostic and medical device companies – are globally known. Since the early twentieth century, they range from the discovery of penicillin to COVID-19 vaccines; the first polio vaccine to the first-ever […]